The 6-hydroxydopamine Rat Model of Parkinson's Disease

被引:18
|
作者
Guimaraes, Rayanne Poletti [1 ]
Ribeiro, Danilo Leandro [1 ]
dos Santos, Keila Bariotto [1 ]
Godoy, Livea Dornela [1 ]
Correa, Mirella Rosine [1 ]
Padovan-Neto, Fernando Eduardo [1 ]
机构
[1] Univ Sao Paulo, Fac Philosophy Sci & Letters Ribeirao Preto, Dept Psychol, Sao Paulo, Brazil
来源
基金
巴西圣保罗研究基金会;
关键词
DOPA-INDUCED DYSKINESIA; MEDIAL FOREBRAIN-BUNDLE; ANIMAL-MODELS; SUBSTANTIA-NIGRA; PARTIAL LESION; BASAL GANGLIA; 6-OHDA; MOTOR; RECOVERY; DEFICITS;
D O I
10.3791/62923
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Motor symptoms of Parkinson's disease (PD)-bradykinesia, akinesia, and tremor at rest-are consequences of the neurodegeneration of dopaminergic neurons in the substantia nigra pars compacta (SNc) and dopaminergic striatal deficit. Animal models have been widely used to simulate human pathology in the laboratory. Rodents are the most used animal models for PD due to their ease of handling and maintenance. Moreover, the anatomy and molecular, cellular, and pharmacological mechanisms of PD are similar in rodents and humans. The infusion of the neurotoxin, 6hydroxydopamine (6-OHDA), into a medial forebrain bundle (MFB) of rats reproduces the severe destruction of dopaminergic neurons and simulates PD symptoms. This protocol demonstrates how to perform the unilateral microinjection of 6-OHDA in the MFB in a rat model of PD and shows the motor deficits induced by 6-OHDA and predicted dopaminergic lesions through the stepping test. The 6-OHDA causes significant impairment in the number of steps performed with the contralateral forelimb.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] Neuroprotective and Antiapoptotic Potential of Trigonelline in a Striatal 6-Hydroxydopamine Rat Model of Parkinson’s Disease
    M. Mirzaie
    M. Khalili
    Z. Kiasalari
    M. Roghani
    Neurophysiology, 2016, 48 : 176 - 183
  • [22] Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease
    Sharma, R
    McMillan, CR
    Tenn, CC
    Niles, LP
    BRAIN RESEARCH, 2006, 1068 (01) : 230 - 236
  • [23] Transcriptome profiling of five brain regions in a 6-hydroxydopamine rat model of Parkinson's disease
    Lyu, Ying
    Huang, Yiying
    Shi, Guiying
    Lei, Xuepei
    Li, Keya
    Zhou, Ran
    Bai, Lin
    Qin, Chuan
    CNS NEUROSCIENCE & THERAPEUTICS, 2021, 27 (11) : 1289 - 1299
  • [24] Neuroprotective effect of pioglitazone in the 6-hydroxydopamine model of Parkinson's disease
    Machado, M. M. F.
    Bassani, T. B.
    Moura, E. L. R.
    Coppola-Segovia, V.
    Zanata, S.
    Vital, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S652 - S652
  • [25] Protective effects of pergolide in a 6-hydroxydopamine model of Parkinson's disease
    Ciobica, A.
    Hritcu, L.
    Artenie, V.
    Padurariu, M.
    JOURNAL OF NEUROLOGY, 2010, 257 : S62 - S62
  • [26] Longitudinal and parallel monitoring of neuroinflammation and neurodegeneration in a 6-hydroxydopamine rat model of Parkinson's disease
    Maia, Serge
    Arlicot, Nicolas
    Vierron, Emilie
    Bodard, Sylvie
    Vergote, Jackie
    Guilloteau, Denis
    Chalon, Sylvie
    SYNAPSE, 2012, 66 (07) : 573 - 583
  • [27] Characterization of a new low-dose 6-hydroxydopamine model of Parkinson's disease in rat
    Penttinen, Anna-Maija
    Suleymanova, Ilida
    Albert, Katrina
    Anttila, Jenni
    Voutilainen, Merja H.
    Airavaara, Mikko
    JOURNAL OF NEUROSCIENCE RESEARCH, 2016, 94 (04) : 318 - 328
  • [28] Depletion of brain glutathione potentiates the effect of 6-hydroxydopamine in a rat model of Parkinson's disease
    García, JC
    Remires, D
    Leiva, A
    González, R
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2000, 14 (03) : 147 - 153
  • [29] Neuroprotective effects of nicotine in a 6-hydroxydopamine model of Parkinson's disease
    Minamino, Hideaki
    Yanagida, Takashi
    Kitamura, Yoshihisa
    Taniguchi, Takashi
    Shimohama, Shun
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 : 227P - 227P
  • [30] Depletion of brain glutathione potentiates the effect of 6-hydroxydopamine in a rat model of Parkinson’s disease
    Julio C. García
    Diadelis Remires
    Aida Leiva
    Ricardo González
    Journal of Molecular Neuroscience, 2000, 14 : 147 - 153